457 related articles for article (PubMed ID: 10222191)
1. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
Pavletich NP
J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
[TBL] [Abstract][Full Text] [Related]
2. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
Suzuki T; Narita T; Uchida-Toita M; Yoshida M
Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662
[TBL] [Abstract][Full Text] [Related]
4. p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer.
Desdouets C; Bréchot C
Pathol Biol (Paris); 2000 Apr; 48(3):203-10. PubMed ID: 10858954
[TBL] [Abstract][Full Text] [Related]
5. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
Nakayama K; Nakayama K
Bioessays; 1998 Dec; 20(12):1020-9. PubMed ID: 10048302
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
Morris MC; Divita G
J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
[TBL] [Abstract][Full Text] [Related]
7. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
[TBL] [Abstract][Full Text] [Related]
8. [CDK inhibitors].
Toyoshima H
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1562-6. PubMed ID: 9279082
[No Abstract] [Full Text] [Related]
9. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase inhibitors.
Fischer PM; Endicott J; Meijer L
Prog Cell Cycle Res; 2003; 5():235-48. PubMed ID: 14593718
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cyclin-dependent kinase inhibitors in leukemia].
Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
[TBL] [Abstract][Full Text] [Related]
13. MAP kinases and CDKs: kinetic basis for catalytic activation.
Lew J
Biochemistry; 2003 Feb; 42(4):849-56. PubMed ID: 12549901
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).
Graña X; Reddy EP
Oncogene; 1995 Jul; 11(2):211-9. PubMed ID: 7624138
[TBL] [Abstract][Full Text] [Related]
15. Cyclin dependent kinase inhibitors.
Harper JW
Cancer Surv; 1997; 29():91-107. PubMed ID: 9338098
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
Jeffrey PD; Tong L; Pavletich NP
Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
[TBL] [Abstract][Full Text] [Related]
17. Interactions of cyclins with cyclin-dependent kinases: a common interactive mechanism.
Heitz F; Morris MC; Fesquet D; Cavadore JC; Dorée M; Divita G
Biochemistry; 1997 Apr; 36(16):4995-5003. PubMed ID: 9125522
[TBL] [Abstract][Full Text] [Related]
18. Novel potent pharmacological cyclin-dependent kinase inhibitors.
Węsierska-Gądek J; Chamrád I; Kryštof V
Future Med Chem; 2009 Dec; 1(9):1561-81. PubMed ID: 21425979
[TBL] [Abstract][Full Text] [Related]
19. Four distinct cyclin-dependent kinases phosphorylate histone H1 at all of its growth-related phosphorylation sites.
Swank RA; Th'ng JP; Guo XW; Valdez J; Bradbury EM; Gurley LR
Biochemistry; 1997 Nov; 36(45):13761-8. PubMed ID: 9374852
[TBL] [Abstract][Full Text] [Related]
20. p21: structure and functions associated with cyclin-CDK binding.
Ball KL
Prog Cell Cycle Res; 1997; 3():125-34. PubMed ID: 9552411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
